Tyndall Capital Partners

Latest statistics and disclosures from TYNDALL CAPITAL PARTNERS L P's latest quarterly 13F-HR filing:

TYNDALL CAPITAL PARTNERS L P portfolio companies for September 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Onconova Therapeutics 78.81 520832 NEW 2.79 0.00
Onconova Therapeutics Inc *w exp 07/07/202 21.19 390624 NEW 1.00 0.00